Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Xiaojia Wang, PhD
CONTACT
Jian Huang, chief doctor
CONTACT
Lead
Zhejiang Cancer Hospital
With
A multi-center, one-arm, open label design study,which is planned to enroll 79 patients with HER2-positive metastatic breast cancer receiving first-line treatment with pyrotinib and docetaxel. The main purpose of this study was to observe the efficacy and safety of first-line treatment with pyrrolidine and docetaxel for HER2-positive metastatic breast cancer.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted